If you are:
Only When Necessary: NEONATAL WITHDRAWAL/RESP.DEPRESS. W/CHRONIC OR HIGH DOSE; SMALL TERATOGENIC RISK
Precaution: INSUFFICIENT DATA AVAIL; LOW LEVELS EXCRETED WITH SHORT TERM USE
An adult over 60:
management or monitoring precaution: Pulmonary-Life threatening respiratory depression is more likely to occur with high doses, SR products, cachexia, or debilitation due to altered pharmacokinetics with poor fat stores, muscle wasting, or altered clearance. Monitor closely at initiation and with dose titration. Neuro/Psych-Risk for increased confusion and delirium. May increase fall risk. Avoid treatment with 3 or more CNS active drugs. Gastrointestinal-Constipation risk. Urogenital-Urinary retention risk.
Giving Abstral Tablet, Sublingual to a child under 12:
Contraindication: Risk of severe respiratory depression. Restricted to opioid tolerant patients. Dose form not indicated for pediatric use.
Severe Precaution: Administration restricted to opioid tolerant patients. Risk of severe respiratory depression.